arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Aldeyra Therapeutics, Inc.

ALDX

$1.55 ▼ -0.04 (-2.52%) at close

14 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Aldeyra Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $93.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -46.8% ↗

FCF / Share $-0.56 ↗

Trailing P/E —

Price / Book 2.1x

FCF Yield —

Debt / Equity 0.35

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-33.85M

↑ +39.4% —

FCF / Share Free cash flow per share

$-0.56

↑ +23.6% —

Long-Term Debt Long-term obligations

$15.30M

— 0.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
EPS Growth YoY (%)	40.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-46.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	39.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	0.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	44.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—
Net Income Growth YoY (%)	39.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-48.8% Weak ↓ Weak Declining Year-over-year change in net income	39.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-7.4% Weak ↑ Weak Improving Year-over-year change in net income	-53.8% Weak ↓ Weak Declining Year-over-year change in net income	38.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-56.4% Weak ↓ Weak Declining Year-over-year change in net income	-74.1% Weak ↓ Weak Declining Year-over-year change in net income	-19.5% Weak ↑ Weak Improving Year-over-year change in net income	-54.7% Weak Weak Year-over-year change in net income	-133.1% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	23.6% Good ↑ Good Improving Year-over-year change in free cash flow	-41.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	47.0% Excellent Excellent Year-over-year change in free cash flow	-23.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	1.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
FCF / Net Income (x)	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-46.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-96.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-43.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-64.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-74.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	7.4% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-48.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-74.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-42.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-82.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-98.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-76.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-610%)	-78.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-624%)	-31.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-309%)	-41.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-374%)	-28.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-287%)	-63.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-521%)	-126.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-943%)	-44.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-399%)	-56.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-476%)	-86.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-676%)	-48.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-424%)	-82.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-650%)	-32.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-316%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Debt to Equity (x)	0.35x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-42%)	0.22x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	0.13x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.11x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	0.08x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	0.27x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-55%)	0.33x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-44%)	—	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.06x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.06x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.22x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-63%)	-0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-105%)	—
Interest Coverage (x)	-20.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-34.28x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20.66x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-37.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-32.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.13x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-104.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-270.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-198.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-177.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-106.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-29.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	-23.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-54.74M	$-39.23M	$15.29M	$-128.08M	$-214.29M	$-61.82M	$-28.38M	$-47.36M	$-18.80M	$-10.62M	$-13.25M	$-7.13M	$-2.13M	$-1.22M
Debt / EBITDA (x)	-0.44x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.26x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.36x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.26x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.28x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.44x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.25x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.05x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.19x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.31x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Basic EPS, GAAP (USD)	$-0.56	$-0.94	$-0.64	$-1.06	$-1.07	—	—	—	—	—	$-1.40	$-2.51	$3.49	—
Free Cash Flow per Share (USD)	$-0.56	$-0.73	$-0.51	$-0.97	$-0.79	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.74	$1.19	$2.02	$2.58	$3.54	$1.54	$1.68	$3.30	$2.07	$1.72	$2.56	$1.65	$-126.31	—
Tangible Book Value per Share (USD)	$0.74	$1.19	$2.02	$2.58	$3.54	$1.54	$1.68	$3.30	$2.07	$1.72	$2.56	$1.65	$-126.31	—
Basic Weighted Avg Shares (shares)	60.06M	59.48M	58.94M	58.41M	54.04M	—	—	—	—	—	8.63M	3.82M	318,429	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$43.97M	$85.47M	$125.55M	$165.66M	$220.98M	$70.65M	$62.26M	$86.30M	$40.61M	$22.83M	$25.97M	$7.43M	$2.67M	—
LT Debt (USD)	$15.30M	$15.30M	$15.29M	$16.34M	$15.50M	$16.04M	$16.04M	—	$1.22M	$1.40M	$1.40M	$1.40M	$1.13M	—
Total Equity (USD)	$44.25M	$71.00M	$119.80M	$151.01M	$205.74M	$59.51M	$48.08M	$86.62M	$39.60M	$21.65M	$24.88M	$6.28M	$-40.22M	$-54.38M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Depreciation Expense (USD)	$251.99K	$249.62K	$262.78K	$258.71K	$264.18K	$56.22K	$96.31K	$71.00K	$37.85K	$35.79K	$18.78K	$1.07K	—	—
Net Income, GAAP (USD)	$-33.85M	$-55.85M	$-37.54M	$-62.02M	$-57.78M	$-37.55M	$-60.83M	$-38.89M	$-22.34M	$-18.70M	$-12.09M	$-5.19M	$13.06M	—
Operating Cash Flow (USD)	$-33.35M	$-43.21M	$-30.33M	$-56.64M	$-42.56M	$-37.49M	$-44.98M	$-29.86M	$-19.22M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 64 quarters

Aldeyra Therapeutics, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ALDX with peers